Overview
This educational guide combines two growth hormone-promoting peptides to amplify natural GH and IGF-1 elevation through complementary mechanisms. CJC-1295 DAC provides sustained stimulation, while Ipamorelin triggers acute secretory pulses.
Composition
CJC-1295 DAC (2mg Vial)
– Long-acting growth hormone-releasing hormone (GHRH) analog
– Duration: ~6–8 days per injection
– Standard reconstitution: 2 mg/mL
Ipamorelin (5mg Vial)
– Selective growth hormone secretagogue
– Half-life: approximately 2 hours
– Induces pulsatile GH spikes
– Standard reconstitution: 2.5 mg/mL
Reconstitution Instructions
CJC-1295 DAC (2mg)
1. Clean rubber stopper with alcohol swab
2. Draw 1.0 mL bacteriostatic water into sterile syringe
3. Inject slowly down vial wall; swirl gently until clear
4. Label with date and store at 2–8°C
5. Use within 30 days; do not freeze
Result: 2 mg/mL solution (20 mcg per unit)
Ipamorelin (5mg)
1. Clean rubber stopper with alcohol swab
2. Draw 2.0 mL bacteriostatic water into sterile syringe
3. Inject slowly; swirl gently until dissolved
4. Refrigerate at 2–8°C
5. Discard after 30 days or if cloudy
Result: 2.5 mg/mL solution (25 mcg per unit)
Dosage Protocols
Standard/Gradual Approach
| Peptide | Weekly Dose | Per Injection | Frequency |
|---|---|---|---|
| CJC-1295 DAC | 1 mg/week | ~50 units (0.5 mL) | 1× weekly |
| Ipamorelin | 200–300 mcg/day | 200–300 mcg | 1–2× daily |
CJC-1295 Alternative: Split into 0.5 mg (25 units) twice weekly for smoother levels.
Advanced/Aggressive Approach
| Peptide | Weekly Dose | Per Injection | Frequency |
|---|---|---|---|
| CJC-1295 DAC | 2 mg/week | ~100 units (1.0 mL) | 1× weekly |
| Ipamorelin | 300 mcg/day | 300 mcg | 1× daily |
CJC-1295 Alternative: Split into 1 mg (50 units) twice weekly.
Administration Schedule
– CJC-1295 DAC: Once weekly (typically Monday)
– Ipamorelin: Once or twice daily (morning and/or bedtime)
– Use separate syringes for each peptide — do not mix in the same vial
– Insert needle at 45–90° into subcutaneous tissue
– Rotate sites between abdomen, thighs, and deltoids
– Cycle duration: 4–6 weeks; assess before repeating
Storage
Lyophilized (powder): Store frozen until reconstitution
Reconstituted vials:
– Temperature: 2–8°C
– Duration: Use within 30 days
– Protect from light; keep upright
– Avoid freeze-thaw cycles
How This Stack Works
CJC-1295 DAC: Long-acting GHRH analog; sustains GH & IGF-1 rise for ~6–8 days.
Ipamorelin: Short-acting GH secretagogue; induces pulsatile GH spikes.
Combined effect: Amplifies baseline GH elevation (via CJC-1295) while adding acute pulses (via Ipamorelin), maximizing overall IGF-1 response.
Potential Benefits
– May improve recovery and sleep quality
– Supports tissue repair and collagen synthesis
– Promotes lean mass gain and body composition changes
– Enhanced physical performance potential
Possible Side Effects
– Injection site irritation
– Headache
– Water retention (mild)
Monitoring recommendations:
– Track IGF-1 levels periodically
– Monitor glucose metabolism
– Assess sleep and recovery markers
Important Considerations
– Do not use if active cancer is present
– Consult a qualified healthcare professional before starting
– Monitor for adverse reactions throughout use
– Maintain proper injection technique to reduce infection risk
– Keep detailed records of dosing and response
– Never combine both peptides in the same syringe
Lifestyle Factors
– Maintain protein-rich diet and adequate hydration
– Engage in regular exercise with sufficient rest days
– Prioritize sleep quality (7–9 hours nightly)
– Manage stress levels
Supplies Checklist
– Insulin syringes (30–100 unit capacity)
– Fresh sterile needles for each injection
– Bacteriostatic water (30 mL minimum)
– Alcohol swabs (1 box)
– Sharps disposal container
Disclaimer
This protocol is provided for research and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any research protocol.